EGFR inhibitor has got a promising efficacy in the treatment of non-small cell lung cancer and head and neck tumor.

• 表皮生长因子受体(EGFR)抑制剂在非小细胞肺癌、头颈部肿瘤的治疗方面取得了较好的疗效。